Zobrazeno 1 - 9 of 9 pro vyhledávání: '"Mimansa Goyal"'
1
Small-Molecule Gankyrin Inhibition as a Therapeutic Strategy for Breast and Lung Cancer
Autor: Dipti Kanabar, Mimansa Goyal, Emma I. Kane, Tejashri Chavan, Abbas Kabir, Xuechun Wang, Snehal Shukla, Joseph Almasri, Sona Goswami, Gizem Osman, Marino Kokolis, Donald E. Spratt, Vivek Gupta, Aaron Muth
Publikováno v: Journal of medicinal chemistry. 65(13)
Gankyrin is an oncoprotein responsible for the development of numerous cancer types. It regulates the expression levels of multiple tumor suppressor proteins (TSPs) in liver cancer; however, gankyrin's regulation of these TSPs in breast and lung canc
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::445014929000f13b6e2282c0fd170988
https://pubmed.ncbi.nlm.nih.gov/35758870
Zobrazit plný text záznamu
2
Cationically modified inhalable nintedanib niosomes: enhancing therapeutic activity against non-small-cell lung cancer
Autor: Snehal K Shukla, Veronica Nguyen, Mimansa Goyal, Vivek Gupta
Publikováno v: Nanomedicine (Lond)
Aim: This study was designed to develop and test nintedanib-loaded niosomes as inhalable carriers for enhancing its therapeutic efficacy via localized drug accumulation and addressing issues such as low bioavailability and severe toxicity. Methods: N
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::547debdeda4a1eb4df4a270a4f21f050
https://doi.org/10.2217/nnm-2022-0045
Zobrazit plný text záznamu
3
Development of gelatin methacrylate (GelMa) hydrogels for versatile intracavitary applications
Autor: Nishant S. Kulkarni, Gautam Chauhan, Mimansa Goyal, Sruthi Sarvepalli, Vivek Gupta
Publikováno v: Biomaterials Science. 10:4492-4507
Applicability of hydrogels as drug delivery systems is on the rise due to their highly tunable degree of polymeric crosslinking to attain varying rates of payload release. Sustaining the release of therapeutic payloads at certain physiological sites
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc3ef508767a8e09170803cb25b3853d
https://doi.org/10.1039/d2bm00022a
Zobrazit plný text záznamu
4
Contributors
Autor: Aashruti Agrawal, Farhan Jalees Ahmad, Faria Ali, null Alka, Mohd. Aqil, M. Arockia Babu, Venkatesh Teja Banala, Sarwar Beg, Aditi Bhat, Valamla Bhavana, Padakanti Sandeep Chary, Vikas Chaudhary, Akash Chaurasiya, Manish K. Chourasia, Harshita Dalvi, Yige Fu, Amruta Gorajiya, Mimansa Goyal, Monica Gulati, Vivek Gupta, Harsha Jain, Dhara Jain, Nitin Jain, Isha Joshi, Kiran Jyoti, Manpreet Kaur, Ayesha Khan, Dharmendra Kumar Khatri, Parveen Kumar, Preeti Kush, Praveen Lakhera, Jitender Madan, Srushti Mahajan, Indrani Maji, Priyanka Maurya, Neelesh Kumar Mehra, Charu Misra, Keerti Mishra, Nidhi Mishra, Dhrubojyoti Mukherjee, Jatinder Kaur Mukker, Jayabalan Nirmal, Raquibun Nisha, Ravi Raj Pal, Vineela Parvathaneni, Ketan Patel, Manali Patki, Rakesh Kumar Paul, Purva Pingle, Ravi Shankar Prasad Singh, Abdul Qadir, Naveen Rajana, Manoj Rawat, Kaisar Raza, Vaskuri G.S. Sainaga Jyothi, Shubhini A. Saraf, Aishwarya Saraswat, Satish Sardana, Deep Shikha Sharma, null Shubhra, Snehal K. Shukla, Neelu Singh, Pankaj Kumar Singh, Priya Singh, Sachin Kumar Singh, Samipta Singh, Shashi Bala Singh, Yuvraj Singh, Rupinder Kaur Sodhi, Veerabomma Haritha Sree, Anitha Sriram, Saurabh Srivastava, Amrendra K. Tiwari, Richa Vartak, Sheetu Wadhwa, Xuechun Wang, Pavan K. Yadav, Sobiya Zafar
Publikováno v: Multifunctional Nanocarriers ISBN: 9780323850414
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1fa321547f8a8e5c189e4e7fc51def72
https://doi.org/10.1016/b978-0-323-85041-4.01002-7
Zobrazit plný text záznamu
7
Nanotechnology Based Repositioning of an Anti-Viral Drug for Non-Small Cell Lung Cancer (NSCLC)
Autor: Vineela Parvathaneni, Nishant S. Kulkarni, Vivek Gupta, Snehal K. Shukla, Mimansa Goyal
Publikováno v: Pharmaceutical Research. 37
Nelfinavir (NFV), a FDA approved antiretroviral drug, has been reported to exhibit cancer cells growth inhibition and increased apoptosis. However, it requires a higher dose leading to toxicity, thus limiting its potential clinical translation. We ai
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b46c75d03c97ec34f22eedbc20675f3
https://doi.org/10.1007/s11095-020-02848-2
Zobrazit plný text záznamu
9
Repurposing Bedaquiline for Effective Non-Small Cell Lung Cancer (NSCLC) Therapy as Inhalable Cyclodextrin-Based Molecular Inclusion Complexes
Autor: Aaron Muth, Mimansa Goyal, Rasha Elbatanony, Srikanth Kolluru, Tejashri Chavan, Vineela Parvathaneni, Nathan Vega, Vivek Gupta, Nitesh K. Kunda
Publikováno v: International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 22, Iss 4783, p 4783 (2021)
Volume 22
Issue 9
There is growing evidence that repurposed drugs demonstrate excellent efficacy against many cancers, while facilitating accelerated drug development process. In this study, bedaquiline (BDQ), an FDA approved anti-mycobacterial agent, was repurposed a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc5296ff9f975fc95dc3018463b6788b
https://doi.org/10.3390/ijms22094783
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje